跳至主要内容
临床试验/JPRN-UMIN000011861
JPRN-UMIN000011861已完成2 期

A phase II study of preoperative concurrent chemoradiotherapy with TS-1/ Oxaliplatin in patients with locally advanced rectal cancer(PerSeUS-RC01) - A phase II study of neoadjuvant SOX + RT for locally advanced rectal cancer(PerSeUS-RC01)

PerSeUS:Perpetual Study estimated-by United Sections in Gifu0 个研究点目标入组 40 人开始时间: 2013年9月25日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) History of Severe drug allergy 2) Active infections (over 38.0 degree) 3) Severe concurrent disease (interstitial pneumonitis or pulmonary fibrosis, poorly controlled diabetes, renal failure or hepatic failure) 4) Severe aberration of electrocardiogram, schemic heart disease, arrhythmia, cardiac infarction or heart failure. 5) Sensory neuropathy 6) Watery diarrhea 7) Massive pleural effusion or ascites 8) Active double cancer (synchronous double cancer or asynchronous double cancer with disease-free duration of 5 years or less) 9) Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers. Males that are currently attempting to produce a pregnancy 10) Current use of flucytosine 11) Positive hepatitis-B antigen 12) Physician concludes that the patient's participation in this trial is inappropriate.

研究者

发起方
PerSeUS:Perpetual Study estimated-by United Sections in Gifu

相似试验